Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography Devices
Diagnostics · 08.03.2026 · 16 (5) · 801
DOI: 10.3390/diagnostics16050801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 08.03.2026. Verfasst von Michael Hafner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, LMU University Hospital, Ludwig-Maximilians-Universität München, Mathildenstraße 8, 80336 Munich, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Swept-source optical coherence tomography angiography (SS-OCTA) enables rapid assessment of retinal microvasculature. However, cross-platform comparability remains limited by device-specific acquisition and image quality characteristics. This study prospectively compared two novel SS-OCTA systems, DREAM (200 kHz) and BMizar (400 kHz).
Methods
Fifty eyes from 25 healthy participants underwent 3 mm × 3 mm macular OCTA imaging with both devices in a single session. Images were analysed using OCTAVA to extract foveal avascular zone (FAZ) area, vessel area density (VAD), total vessel length (TVL), node counts, fractal dimension (FD), median vessel length (MVL) in SCP, and mean vessel diameter (MVD) in DCP. Image quality was assessed using FAZ-noise rate, contrast-to-noise ratio (CNR), and FAZ noise-floor standard deviation. Paired comparisons were performed using Wilcoxon signed-rank tests and Cliff’s delta.
Results
BMizar acquisition time was shorter than DREAM for the evaluated 3 × 3 mm protocol (median 5.36 s vs. 9.93 s), reflecting differences in A-scan rate and protocol implementation; acquisition time is therefore reported descriptively. In the SCP, DREAM yielded lower VAD (41.9% vs. 48.8%) and fewer nodes (1547 vs. 1879) but exhibited markedly less background noise (noise-floor SD 4.1 vs. 57.9) and substantially higher CNR (16.7 vs. 0.82). DREAM also showed longer MVL (45 vs. 39 µm) and higher FD (1.98 vs. 1.97; δ = 0.90). In the DCP, DREAM demonstrated smaller FAZ areas (0.27 vs. 0.42 mm2), thinner MVD (14 vs. 25 µm), higher node counts (3144 vs. 2301), longer TVL (223.6 vs. 206.2 mm), and higher FD (1.98 vs. 1.97), whereas VAD was higher on BMizar (32.96% for DREAM vs. 49.93% for BMizar). FAZ-noise rates were consistently higher for BMizar in both plexuses.
Conclusions
Both devices provide reliable SS-OCTA imaging, but with distinct strengths. DREAM delivers higher vascular continuity and more reliable FAZ and DCP quantification, whereas BMizar achieves faster acquisition at the cost of noise, inflating SCP density and distorting FAZ-based metrics. Awareness of these characteristics is essential to ensure the valid use of OCTA biomarkers in clinical and research applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, LMU University Hospital, Ludwig-Maximilians-Universität München, Mathildenstraße 8, 80336 Munich, Germany.
ORCID-Profile: Michael Hafner, Siegfried G Priglinger
Zitieren
APA
Hafner, M., Deschler, D. J. P., Kufner, A., Katscher, L. M., Priglinger, S. G., & Gerhardt, M. J. (2026). Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography Devices. Diagnostics, 16(5), 801. https://doi.org/10.3390/diagnostics16050801
Vancouver
Hafner M, Deschler DJP, Kufner A, Katscher LM, Priglinger SG, Gerhardt MJ. Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography Devices. Diagnostics. 2026;16(5):801. doi:10.3390/diagnostics16050801
BibTeX
@article{Hafner2026,
author = {Hafner, Michael and Deschler, Daniel J P and Kufner, Alexander and Katscher, Lisa M and Priglinger, Siegfried G and Gerhardt, Maximilian J},
title = {Quantitative Comparison of Two Novel Swept-Source Optical Coherence Tomography Angiography Devices},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {5},
pages = {801},
doi = {10.3390/diagnostics16050801}
}
EUVIMED